Document And Entity Information Document Information [Table] Document Information [Line Items] Document And Entity Information Document Type Document Type Entity Registrant Name Entity Registrant Name Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Consolidated Balance Sheets Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of year Cash and cash equivalents at beginning of year Cash and cash equivalents Deferred Costs, Current Deferred issuance cost Prepaid Expense, Current Prepaid expenses and other current assets Assets, Current Total current assets Deposits Assets, Noncurrent Security deposit Property, Plant and Equipment, Net Furniture and equipment, net Operating Lease, Right-of-Use Asset Right-of-use lease assets Assets Total assets Total assets Liabilities and Equity [Abstract] Liabilities and shareholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total Employee-related Liabilities, Current Accrued compensation Operating Lease, Liability, Current Lease liabilities, current Convertible Debt, Current Convertible debt Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Non-current liabilities: Operating Lease, Liability, Noncurrent Lease liabilities, net of current portion Liabilities Total liabilities Commitments and contingencies. Commitments and contingencies (Note 10) Stockholders' Equity Attributable to Parent [Abstract] Shareholders' equity: Preferred Stock, Value, Issued Preferred stock, 350,000 shares authorized; none issued or outstanding at December 31, 2025 and December 31, 2024 Common Stock, Value, Issued Common stock, $0.001 par value; 75,000,000 shares authorized; 10,086,130 and 2,514,499 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Balance Balance Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Statement [Table] Statement [Line Items] Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value (per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Balance (in shares) Balance (in shares) Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Consolidated Statements of Operations Product and Service [Axis] Product and Service [Domain] Grant revenue Revenues Revenues Total revenues Cost of Revenue Cost of revenues Gross Profit Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expense): Foreign Currency Transaction Gain (Loss), before Tax Foreign currency transaction (loss) gain Interest Income (Expense), Nonoperating, Net Interest income, net UK research and development incentives. Uk Research And Development Incentives Research and development incentives Amount of income related to employee retention credit under CARES Act. Employee retention credit, CARES ACT CARES Act employee retention credit Other Nonoperating Income Other income Amount of expense (income) related to adjustment to fair value of convertible debt. Fair Value Adjustment of Convertible Debt Change in fair value of convertible debt Change in fair value of convertible debt Nonoperating Income (Expense) Total other income Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss before income taxes Net loss before income taxes Income Tax Expense (Benefit) Income tax benefit Income tax benefit Net Income (Loss) Available to Common Stockholders, Basic Net loss applicable to common stockholders Earnings Per Share, Basic Basic net loss per share (in Dollars per share) Earnings Per Share, Diluted Diluted net loss per share (in Dollars per share) Weighted Average Number of Shares Outstanding, Basic Basic weighted average common shares outstanding (in Shares) Weighted Average Number of Shares Outstanding, Diluted Diluted weighted average common shares outstanding (in Shares) Consolidated Statements of Comprehensive Loss Net Income (Loss) Attributable to Parent Net loss Net loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive income: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation adjustments Foreign currency translation adjustment Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Consolidated Statements of Changes in Equity and Shareholders' Equity (Deficit) Equity Components [Axis] Equity Component [Domain] Common Stock Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Accumulated Deficit Sale of Stock [Axis] Sale of Stock [Domain] Represents the information pertaining to public offering. Public Offering Public offering Represents the member information pertaining to B. Riley Sales Agreement. At Market Issuance Sales Agreement Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to pre-funded warrants. Pre-funded Warrant [Member] Pre-funded warrants Represents information pertaining to the existing warrants. Existing Warrants [Member] Existing Warrants Represents information pertaining to the new warrants. New Warrants [Member] New warrants Stock Issued During Period, Value, New Issues Issuance of common stock pursuant to At Market Issuance Sales Agreement Stock Issued During Period, Shares, New Issues Number of shares issued Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Issuance costs The value of stock and pre-funded warrants issued during the period. Stock and Pre-funded Warrants Issued During Period, Value Issuance of common stock and pre-funded warrants in connection with public offering The number of stock and pre-funded warrants issued during the period. Stock and Pre-funded Warrants Issued During Period, Shares Issuance of common stock and pre-funded warrants in connection with public offering (in shares) Stock Issued During Period, Value, Issued for Services Issuance of common stock to vendors Stock Issued During Period, Shares, Issued for Services Issuance of common stock to vendors (in shares) Value of shares issued during the period as a result of reverse stock split Stock Issued During Period, Value, Reverse Stock Splits Fractional shares issued in June 2024 reverse stock split Stock Issued During Period, Shares, Reverse Stock Splits Fractional shares issued in June 2024 reverse stock split (in shares) Value of stock issued during the period on exercise of warrants. Stock Issued During Period, Value, Exercise Of Warrants Issuance of common stock upon exercise of warrants Number of shares issued on exercise of warrants. Stock Issued During Period, Share Exercise Of Warrants Issuance of common stock upon exercise of warrant Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing warrants. Includes, but is not limited to, legal and accounting fees and direct costs associated with warrant issuances. Adjustments to Additional Paid in Capital, Warrants Issued, Issuance Costs Issuance costs associated with warrant inducement Adjustments to Additional Paid in Capital, Warrant Issued Warrant modification - incremental fair value Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of common stock from conversion of debt Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of common stock from conversion of debt (in shares) APIC, Share-based Payment Arrangement, Increase for Cost Recognition Share-based compensation expense Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock spilt effective from June 5, 2024 Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Cost, Depreciation and Amortization Amortization and depreciation Operating Lease, Right-of-Use Asset, Amortization Expense Non-cash lease expense Share-based Payment Arrangement, Noncash Expense Share-based compensation Share-Based Compensation Issuance of Stock and Warrants for Services or Claims Issuance of common stock to vendors for services Change in operating assets and liabilities: Increase (Decrease) in Accounts and Other Receivables Contracts and grants receivable Increase (Decrease) in Prepaid Expense Prepaid expenses and other current assets Increase (Decrease) in Other Receivables Research and development incentives receivable Increase (Decrease) in Operating Lease Liability Operating lease liability Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Other Employee-Related Liabilities Accrued compensation Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net cash flows from operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of furniture and equipment Net Cash Provided by (Used in) Investing Activities Net cash flows from investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities: Proceeds from issuance of common stock pursuant to FBR At-the-Market Sales Agreement, Proceeds From Issuance Of Common Stock Pursuant To Market Sales Agreement Proceeds from issuance of common stock pursuant to At Market Issuance Sales Agreement Payments of Stock Issuance Costs Stock issuance costs associated The amount of proceeds from issuance of common stock and warrants. Proceeds from Issuance of Common Stock and Warrants Proceeds from issuance of common stock and pre-funded warrants Proceeds from Warrant Exercises Proceeds from the exercise of warrants The cash outflow for the cost incurred directly with the issuance and modification of warrants as per the inducement agreement. Payments Of Warrant Issuance Costs Upon Inducement Issuance costs associated with warrant inducement Total issuance costs Repayments of Convertible Debt Convertible debt repayments Repayment of debt principal Net Cash Provided by (Used in) Financing Activities Net cash flows from financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Effect of exchange rate on cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental information: Income Taxes Paid Cash paid for state income taxes Cash paid for interest Additional Cash Flow Elements [Abstract] Cash paid for lease liabilities: Amount of cash outflow from operating lease. Operating Lease Paid Operating lease Noncash Investing and Financing Items [Abstract] Non-cash investing and financing activities: Debt Conversion, Converted Instrument, Amount Pontifax conversion of portion of debt principal into common stock Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use assets obtained in exchange for lease liabilities Deferred issuance cost reclassified to additional-paid-in capital. NoncashOrPartNoncashDeferredIssuanceCostReclassifiedToAdditionalPaidInCapital Deferred issuance cost reclassified to additional paid-in capital The amount of stock issuance costs included in accounts payable and accrued expenses. Stock Issuance Costs Included in Accounts Payable And Accrued Expenses Offering costs included in accounts payable and accrued expenses The amount of incremental fair value of warrants recognized as issuance cost of the warrant exercise. Issuance Cost Of Warrant Exercise Warrant modification - incremental value Nature of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of Business Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Leases Lessee, Leases [Text Block] Leases Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Debt Debt Disclosure [Text Block] Debt Income Taxes Income Tax Disclosure [Text Block] Income Taxes Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Shareholders' Equity Stock Option Plans and Warrants to Purchase Common Stock. Share-based Payment Arrangement [Text Block] Stock Option Plans and Warrants to Purchase Common Stock Concentrations Concentration Risk Disclosure [Text Block] Concentrations Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Operating Segments Segment Reporting Disclosure [Text Block] Operating Segments Subsequent Events Subsequent Events [Text Block] Subsequent Events Use of Estimates, Policy [Policy Text Block] Use of Estimates and Assumptions Consolidation, Policy [Policy Text Block] Principles of Consolidation Segment Reporting, Policy [Policy Text Block] Operating Segments Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Fair Value Measurement, Policy [Policy Text Block] Fair Value of Financial Instruments Deferred Charges, Policy [Policy Text Block] Deferred Issuance Costs Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Share-based Payment Arrangement [Policy Text Block] Share-Based Compensation Lessee, Leases [Policy Text Block] Leases Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Transactions and Translation Income Tax, Policy [Policy Text Block] Income Taxes New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Earnings Per Share, Policy [Policy Text Block] Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive outstanding instruments which were not included in the computation of diluted EPS Lease, Cost [Table Text Block] Schedule of lease expense Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of federal and state statutory tax rates and the provision for income tax benefit Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of deferred tax assets and liabilities Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of federal and state statutory tax rates and the provision for income tax benefit Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type Award Type [Domain] All Award Types Represents the information pertaining to 2025 Equity Incentive Plan. Equity Incentive Plan 2025 [Member] Grant 2025 plan Stock options Stock options Share-based Payment Arrangement Warrants Common stock purchase warrants Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Payment Arrangement, Activity [Table Text Block] Schedule of shares available for grant under the 2015 plan Share-based Payment Arrangement, Option, Activity [Table Text Block] Schedule of activity under the 2005 plan and the 2015 plan Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms ShareBasedPaymentsArrangementOptionExercisePriceRangeTableTextBlock Schedule of weighted-average exercise price, by price range, for outstanding options to purchase common stock Share-based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of share-based compensation expense Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Schedule of warrant activity Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Schedule of remaining life, by grant date, for outstanding warrants Contractual Obligation, Fiscal Year Maturity [Table Text Block] Schedule of contractual obligations Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of operating segments Collaborative Arrangement and Arrangement Other than Collaborative [Table] HyBryte HyBryte Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event At market issuance sales is where sales agent will sell shares on behalf of the company. At Market Issuance Sales [Member] At Market Issuance sales Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Nature of business: Number of Operating Segments Number of operating segments Collaborative Arrangement, Revenue Not from Contract with Customer, Statement of Income or Comprehensive Income [Extensible Enumeration] Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Revenue from collaborative arrangement Guarantee Obligations Term Duration Guarantee Obligations Term Duration Term (in years) The amount of working capital, carrying value. Working Capital Carrying Value Working capital The aggregate value of shares to be issued or sold by the entity as per the stock transaction. Sale of Stock, Aggregate Value of Shares To Be Issued in Transaction Aggregate offering price The aggregate value of common shares reserved for future issuance as per the agreement. Common Stock, Value Of Shares Reserved for Future Issuance Aggregate value of shares remaining from agreement Schedule of Finite-Lived Intangible Assets [Table] Title of Individual [Axis] Title of Individual [Domain] Directors Restructuring Type [Axis] Type of Restructuring [Domain] Termination benefits Finite-Lived Intangible Assets [Line Items] Summary of Significant Accounting Policies Impairment of Intangible Assets, Finite-lived Impairment of long-lived assets Estimated period over which an employee is required to provide service in exchange for equity-based payment award. Share - Based Compensation Arrangement Service Period Requisite period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Option vesting rights Period from grant date that an equity based award expires. Share based Compensation Expiration Period Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Volatility rate minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Volatility rate maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk free interest rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk free interest rate, maximum Unrecognized Tax Benefits, Interest on Income Taxes Accrued Interest and penalties Schedule of potentially dilutive adjustments to the weighted average number of common shares excluded from the calculation [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Convertible debt securities Convertible debt Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities excluded Lessee, Lease, Description [Table] Scenario [Axis] Scenario [Domain] Represents information pertaining to lease payments applicable from November 2026 to October 2027. Lease Payments Applicable From November 2026 To October 2027 [Member] From November 2026 to October 2027 Represents information pertaining to lease payments applicable from November 2027 until expiration. Lease Payments Applicable From November 2027 Until Expiration [Member] From November 2027 until expiration Lessee, Lease, Description [Line Items] Amount of lease rental per month Lease Rental Per Month Lease rent per month Contractual cash payments, operating lease Contractual cash payments for the remaining lease term Lessee, Operating Lease, Liability, to be Paid, Year One 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three 2028 Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less implied interest Lessee, Operating Lease, Liability, to be Paid Total Lessee, Operating Lease, Discount Rate Operating Lease, Discount rate applied Lessee, Operating Lease, Term of Contract Remaining lease term (months) Lease expense Operating Lease, Cost Lease expense Accrued Professional Fees, Current Clinical trial expenses Other Accrued Liabilities, Current Other Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Convertible Debt [Member] Convertible debt Counterparty Name [Axis] Counterparty Name [Domain] Represents the member information pertaining to Pontifax Medison Finance. Pontifax Medison Finance [Member] Pontifax Represents the member information pertaining to first shares of common stock issuable upon conversion. First 36,790 shares of common stock issuable upon conversion Represents information relating to the conversion price as per the loan agreement amendment for the first tranche. Loan Agreement Amendment 2024, Conversion Price, Tranche One [Member] Conversion price for First 501,648 shares Represents information relating to the conversion price as per the loan agreement amendment for the second tranche. Loan Agreement Amendment 2024, Conversion Price, Tranche Two [Member] Conversion price for Remaining shares Debt Instrument [Axis] Debt Instrument, Name [Domain] First tranche. First Tranche [Member] First tranche Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum Debt instruments Debt instrument, face amount Debt instrument, face amount Debt Instrument, Interest Rate, Stated Percentage Interest rate percentage Line of Credit Facility, Commitment Fee Percentage Unused line of credit fee, as a percent The period during which payment on the debt is for interest only, and payments of principal are deferred until after this period. Debt Instrument, Period Principal Payment Deferred Interest-only period Convertible Notes Payable Convertible note Amount repaid Amount repaid Outstanding principal Represents the reduction in conversion price to percentage of closing price of the common stock on the day before the delivery of the conversion notice. Reduction in conversion price as percentage of closing price of the common stock on the day before the delivery of the conversion notice Reduction in conversion price as percentage of closing price of the common stock on the day before the delivery of the conversion notice Represents the reduction in conversion price. Reduction in conversion price Reduction in conversion price Debt Instrument, Convertible, Conversion Price Conversion price The total number of shares that the holder of the debt instrument would receive if the debt was converted to equity. Debt Instrument, Convertible, Number of Shares To Be Issued Common stock issuable upon conversion Deferred Tax Assets, Operating Loss Carryforwards, State and Local NOL for Federal tax Deferred Tax Assets, Operating Loss Carryforwards, Domestic NOL for State tax Deferred Tax Assets, Operating Loss Carryforwards, Foreign NOL for Foreign tax Tax Credit Carryforward, Amount Various tax credits, amount Operating Loss Carryforwards NOL carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized research and development costs. Deferred Tax Assets, Capitalized Research and Development Costs Capitalized research and development Deferred tax asset due to capitalized research and development Unrecognized Tax Benefits Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Interest or penalties accrued State and Local Income Tax Expense (Benefit), Continuing Operations State & Local Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carry forwards Deferred Tax Assets, Tax Credit Carryforwards Orphan drug and research and development credit carry forwards Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Equity based compensation Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible and fixed assets. Deferred Tax Assets, Intangible And Fixed Assets Intangible and fixed assets Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liability. Deferred Tax Assets, Lease Liability Lease Liability Deferred Tax Assets, Other Other Deferred Tax Assets, Gross Total Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred Tax Assets, Net of Valuation Allowance Net deferred tax assets Amount of deferred tax liability attributable to taxable temporary differences from right of use assets Deferred Tax Liabilities, Right of Use Assets Right of use asset Deferred Tax Liabilities, Gross Total gross deferred tax liabilities Deferred Tax Assets, Net Net deferred tax assets Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Federal tax at statutory rate Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State tax benefits, plus sale of NJ NOL, net of federal benefit Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Orphan drug and research and development credits Effective Income Tax Rate Reconciliation, Deduction, Percent Permanent differences Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Foreign NOL adjustments It pertains to the income tax rate reconciliation relating to the expiration of tax attributes. Effective Income Tax Rate Reconciliation Expiration Of Tax Attributes Expiration of tax attributes Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance Effective Income Tax Rate Reconciliation, Percent Income tax benefit Schedule of Stock by Class [Table] Represents the information pertaining to pre-funded warrants. Pre-funded warrants Represents information pertaining to warrant modification and new warrants. Warrant Modification And New Warrants [Member] Warrant modification and new warrants Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Expected Dividend Rate [Member] Dividend yield Measurement Input, Expected Term [Member] Expected term Measurement Input, Price Volatility [Member] volatility Measurement Input, Risk Free Interest Rate [Member] Risk free interest Class of Stock [Line Items] Shareholders' Equity Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants closing, Balance Warrants opening, Balance Number of common warrants to purchase shares issued Share Price Shares issued price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Warrants and Rights Outstanding New warrants issued Represents the weighted average share price for shares issued. Weighted average price Weighted average price (per share) The percentage of the gross proceeds from sale of stock to be paid as compensation to the counter party as per the terms of stock transaction. Sale Of Stock, Compensation Percentage On Gross Proceeds Percentage of gross proceeds from sales of shares under ATM The percentage of the number of shares issued on existing warrants that is agreed to be issued as part of new warrants as per the inducement agreement. Class Of Warrant Or Right Percentage Of Existing Warrant Shares To New Warrant Share Issues Percentage of numbers of shares issued upon exercise of existing warrants The amount of financial and legal fees incurred upon the issuance of warrants by the entity during the period. Warrant Issuance Costs Financial And Legal Fees Financial advisory, banker, and legal fees The number of warrants issued that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Warrants And Rights Issued Shares Aggregate warrants issued (shares) Warrants and Rights Outstanding, Measurement Input Warrants and Rights Outstanding No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) [Table] Plan Name [Axis] Plan Name [Domain] Grant 2015 Plan. Grant 2015 Plan Represents the information pertaining to 2005 Equity Incentive Plan . Equity Incentive Plan 2005 [Member] Equity incentive No definition available. Stock Option Plans and Warrants to Purchase Common Stock Common Stock, Capital Shares Reserved for Future Issuance Future issuance Shares reserved for future issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Shares available for grant Shares available for grant Shares available for grant The number of equity programs. Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Equity Programs Number of equity programs Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average exercise price (in Dollars per share) Weighted average exercise price Weighted Average Exercise Price, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance Shares issues (in shares) Share-based Payment Arrangement, Expensed and Capitalized, Amount Total compensation cost (in Dollars) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock option expected year Shares available for grant under the 2015 Plan No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of shares available for grant under the 2025 plan [Table] Stock Option Plans And Warrants To Purchase Common Stock Details Schedule Of Shares Available For Grant Under 2025 Plan [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Shares granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options granted Number of options issued Warrants, Granted Additional number of common shares reserved for future issuance. Common Stock, Capital Shares Reserved for Future Issuance, Additions Shares reserved for issuance, additions Activity under the 2005 Plan and the 2015 Plan Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Options Exercise Price outstanding ending balance Weighted Average Options Exercise Price outstanding beginning balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average price per share (in Dollars per share) Weighted Average Exercise Price, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted Average Options Exercise Price Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Options Exercised Exercise of common stock options (in shares) Schedule of weighted-average exercise price, by price range, for outstanding options to purchase common stock [Abstract] No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of weighted-average exercise price, by price range, for outstanding options to purchase common stock [Table] Exercise Price Range [Axis] Exercise Price Range [Domain] Represents the information pertaining to exercise price range from $1.37 - $10.78. Exercise Price Range 1.37 to 10.78 [Member] $1.37 - $10.78 Represents the information pertaining to exercise price range from $129.60 - $640.80. Exercise Price Range 129.60 to 640.80 [Member] $129.60 - $640.80 Represents the information pertaining to exercise price range of $1,776. Exercise Price Range 1776 [Member] $1,776.00 No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of weighted-average exercise price, by price range, for outstanding options to purchase common stock [Line Items] Weighted-average exercise price, by price range, for outstanding options to purchase common stock Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Exercise price, lower limit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Exercise Price (in Dollars per share) Exercise price, upper limit Weighted Average Remaining Contractual Life in Years. Share based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Averages Remaining Contractual Term 2 Weighted Average Remaining Contractual Life in Years Outstanding Options. Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Option Outstanding Options Exercisable Options. Share Based Compensation Share Authorized Under Stock Option Plan Exercise Price Range Number Of Exercisable Options Exercisable Options Share-based compensation expense No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of share-based compensation expense [Table] Income Statement Location [Axis] Income Statement Location [Domain] Research and development General and administrative No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of share-based compensation expense [Line Items] Share-based compensation expense Warrants to Purchase Common Stock No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of warrant activity [Table] No definition available. Stock Option Plans and Warrants to Purchase Common Stock (Details) - Schedule of warrant activity [Line Items] Warrants to Purchase Common Stock Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Share Based Compensation Arrangement By Share Based Payment Warrant Outstanding Weighted Average Exercise Price Weighted Average Exercise Price closing, Balance Weighted Average Exercise Price opening, Balance Remaining life, by grant date, for outstanding warrants Share-based Payment Arrangement, Option, Exercise Price Range [Table] Grant Date One. 05/09/2023 Grant Date Two. 04/22/2024 Grant Date Three. 09/25/2025 Grant Date Four. 8/2/2018 [Member] 09/29/2025 Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Share-based Payment arrangement, option, exercise price range Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Remaining Contractual Life in Years Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Outstanding Warrants Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Exercisable Warrants Other Commitments [Table] Grantee Status [Axis] Grantee Status [Domain] Share-based Payment Arrangement, Employee [Member] Employee Represents information pertaining to Dr. Schaber. Dr. Schaber [Member] Dr. Schaber Category of Item Purchased [Axis] Long-term Purchase Commitment, Category of Item Purchased [Domain] Research and Development Arrangement Research and Development Information pertaining to Asset Purchase Agreement. Asset Purchase Agreement Other Commitments [Line Items] Commitments and Contingencies Contractual Obligation Contractual obligation Total The milestone amount that is payable upon attainment of approval. Milestone Payment Upon Attainment Of Approval Milestone payment upon attainment of approval The amount of cash outflow for payment of royalty and milestone. Payment of Royalty And Milestone Amounts Payment of royalty and milestone amounts Percentage of ownership outstanding stock. Percentage Of Ownership Outstanding Stock Ownership of company outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares of common stock issuable Long-term Purchase Commitment [Table] Lease Agreements Leases Long-term Purchase Commitment [Line Items] Commitments and Contingencies Contractual Obligation, Fiscal Year Maturity Schedule [Abstract] Future contractual obligations Contractual Obligation, to be Paid, Year One 2026 Contractual Obligation, to be Paid, Year Two 2027 Contractual Obligation, to be Paid, Year Three 2028 Contractual Obligation, to be Paid, Year Four 2029 Contractual Obligation, to be Paid, Year Five 2030 Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Domain] Total Segments Adjustments Corporate Represents the aggregate total of reconciling items and elimination items. Adjustments. Segments [Axis] Segments [Domain] BioTherapeutics. Specialized BioTherapeutics Public Health Solutions Segment Reporting Information [Line Items] Segment reporting Number of Reportable Segments Number of reportable segments The adjusted net result for the period of deducting operating expenses from operating revenues. Adjusted Operating Income Loss Adjusted loss from operations Depreciation, Depletion and Amortization Depreciation and amortization The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business) including one time gain (loss). Non-operating Income Loss Including One Time Gain (Loss) Other (expenses) income, net Other Nonoperating Income (Expense) Other income (expense), net Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Events Represents information pertaining to threshold percentage of compensation from gross proceeds. Threshold Percentage of Compensation from Gross Proceeds